ATARA BIOTHERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Common Stock, Capital Shares Reserved for Future Issuance of 948.37 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-12
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 948.37K shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 619.79K shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 682.42K shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 747.62K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 948.37K shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 619.79K shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 682.42K shares 10-K · filed 2026-03-16 | |
| 2025-09-30 | 747.62K shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 852.93K shares 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 1.07M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 1.14M shares 10-K · filed 2025-03-07 | |
| 2024-09-30 | 1.25M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 1.33M shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 29.00M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 25.11M shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 26.74M shares 10-Q · filed 2023-11-01 | |
| 2023-06-30 | 27.56M shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 29.21M shares 10-Q · filed 2023-05-08 | |
| 2022-12-31 | 24.65M shares 10-K · filed 2023-02-08 | |
| 2022-09-30 | 25.40M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 25.92M shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 25.37M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 20.97M shares 10-K · filed 2022-02-28 | |
| 2021-09-30 | 21.44M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 20.29M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 20.97M shares 10-Q · filed 2021-05-04 | |
| 2020-12-31 | 17.13M shares 10-K · filed 2021-03-01 | |
| 2020-09-30 | 17.51M shares 10-Q · filed 2020-11-09 | |
| 2020-06-30 | 16.34M shares 10-Q · filed 2020-08-05 | |
| 2020-03-31 | 16.75M shares 10-Q · filed 2020-05-06 | |
| 2019-12-31 | 14.26M shares 10-K · filed 2020-02-27 | |
| 2019-09-30 | 14.49M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 14.54M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 14.75M shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 12.58M shares 10-K · filed 2019-02-26 | |
| 2018-09-30 | 12.99M shares 10-Q · filed 2018-11-06 | |
| 2018-06-30 | 13.30M shares 10-Q · filed 2018-08-01 | |
| 2018-03-31 | 13.74M shares 10-Q · filed 2018-05-08 | |
| 2017-12-31 | 11.28M shares 10-K · filed 2018-02-27 | |
| 2017-09-30 | 11.41M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 11.30M shares 10-Q · filed 2017-08-07 | |
| 2017-03-31 | 11.28M shares 10-Q · filed 2017-05-04 | |
| 2016-12-31 | 9.77M shares 10-K · filed 2017-03-09 | |
| 2016-09-30 | 9.85M shares 10-Q · filed 2016-11-04 | |
| 2016-06-30 | 9.91M shares 10-Q · filed 2016-08-08 | |
| 2016-03-31 | 6.64M shares 10-Q · filed 2016-05-06 | |
| 2015-12-31 | 4.35M shares 10-K · filed 2016-03-04 | |
| 2014-12-31 | 3.78M shares 10-K · filed 2015-02-26 | |
| 2013-12-31 | 122.90M shares 10-K · filed 2015-02-26 | 15.13M shares 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |